Clonal Hematopoiesis and Premalignant Diseases.
Ontology highlight
ABSTRACT: Clonal hematopoiesis (CH) arises when mutations in the hematopoietic system confer a fitness advantage to specific clones, thereby favoring their disproportionate growth. The presence of CH increases with age and environmental exposures such as cytotoxic chemotherapy or radiotherapy. The most frequent mutations occur in epigenetic regulators, such as DNMT3A, TET2, and ASXL1, leading to dysregulation of tumor suppressor function, pathogen response, and inflammation. These dysregulated processes elevate risk of overall mortality, cardiovascular disease, and eventual hematologic malignancy (HM). CH is likely acting as an initiating event leading to HM when followed by cooperating mutations. However, further evidence suggests that CH exerts a bystander influence through it
SUBMITTER: Kaner J
PROVIDER: S-EPMC7117948 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA